(Q46382821)

English

Pharmacokinetics and pharmacodynamics of PEGylated IFN-beta 1a following subcutaneous administration in monkeys

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/15771230

Pharmacokinetics and pharmacodynamics of PEGylated IFN-beta 1a following subcutaneous administration in monkeys (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/15771230

pharmacokinetics

1 reference

based on heuristic

inferred from title

pharmacodynamics

1 reference

based on heuristic

inferred from title

William J Jusko

3

object named as

William J Jusko

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/15771230

author name string

Donald E Mager

1

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/15771230

Berend Neuteboom

2

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/15771230

publication date

1 January 2005

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/15771230

Pharmaceutical Research

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/15771230

22

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/15771230

1

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/15771230

58-61

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/15771230

Improved pharmacokinetic properties of a polyethylene glycol-modified form of interferon-beta-1a with preserved in vitro bioactivity.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15771230

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Receptor-mediated pharmacokinetics and pharmacodynamics of interferon-beta1a in monkeys

1 reference

https://pubmed.ncbi.nlm.nih.gov/15771230

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of pegylation on pharmaceuticals

1 reference

https://pubmed.ncbi.nlm.nih.gov/15771230

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Modulation of the pharmacokinetics and pharmacodynamics of proteins by polyethylene glycol conjugation

1 reference

https://pubmed.ncbi.nlm.nih.gov/15771230

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacologic target-mediated drug disposition

1 reference

https://pubmed.ncbi.nlm.nih.gov/15771230

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Modeling viral and drug kinetics: hepatitis C virus treatment with pegylated interferon alfa-2b

1 reference

https://pubmed.ncbi.nlm.nih.gov/15771230

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacodynamic modeling of time-dependent transduction systems

1 reference

https://pubmed.ncbi.nlm.nih.gov/15771230

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of four basic models of indirect pharmacodynamic responses

1 reference

https://pubmed.ncbi.nlm.nih.gov/15771230

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Receptor-mediated transport of peptide hormones and its importance in the overall hormone disposition in the body

1 reference

https://pubmed.ncbi.nlm.nih.gov/15771230

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pegylated interferon-alpha2b: pharmacokinetics, pharmacodynamics, safety, and preliminary efficacy data. Hepatitis C Intervention Therapy Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/15771230

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of an indirect pharmacodynamic stimulation model of MX protein induction to compare in vivo activity of interferon alfa-2a and a polyethylene glycol-modified derivative in healthy subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/15771230

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11095-004-9009-Z

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/15771230

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/15771230

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46382821&oldid=2144083947"